[Translation] To evaluate the efficacy, safety, and immunogenicity of subcutaneous injections of MW05 or Jinyuri® per cycle for the prevention of chemotherapy-induced neutropenia in breast cancer patients in a multicenter, randomized, double-blind, drug-controlled parallel setting Phase II/III clinical study
以津优力®作为阳性对照,比较MW05在乳腺癌患者中预防化疗引起的中性粒细胞减少症的有效性、安全性和免疫原性。
[Translation] The efficacy, safety and immunogenicity of MW05 in the prevention of chemotherapy-induced neutropenia in breast cancer patients were compared with Jinyuri® as a positive control.